Chris Shoff is a partner in Cooley's business department and is a member of the Firm's Emerging Companies practice group. Mr. Shoff joined the Firm in 2012 and is a founding partner of its Los Angeles office.
Mr. Shoff focuses his practice on corporate and securities law with an emphasis on representing emerging growth and established technology, clean technology, medical device, biotech and healthcare services companies and the venture capital firms, strategic investors and investment banks that finance these companies. Mr. Shoff has extensive experience in venture capital financings, mergers and acquisitions and public offerings. He also regularly counsels companies on securities, corporate governance and SEC reporting and disclosure matters.
Mr. Shoff's venture capital financing experience includes representation of companies and investors in over 200 equity and debt financings. His core practice consists of representing companies in these transactions, which have been led by some of the leading venture capital firms, strategic investors and angel investors. Mr. Shoff also regularly represents corporate investors such as Pfizer Inc. (PFE) in their strategic investments.
Mr. Shoff also regularly also regularly represents both selling companies and acquirors in merger and acquisition transactions, including the representation of numerous companies in sell-side transactions constituting successful liquidation events, such as AWR Corporation in its acquisition by National Instruments Corporation (NATI), Core Mobility, Inc. in its acquisition by Smith Micro Software, Inc. (SMSI), Altiris, Inc. in its acquisition by Symantec Corporation (SYMC), Interest.com, Inc. in its acquisition by Bankrate, Inc. (RATE), Performics Inc. in its acquisition by DoubleClick Inc., and Xactware, Inc. in its acquisition by ISO Insurance Solutions, Inc. Mr. Shoff also regularly represents acquirors such as QUALCOMM Incorporated (QCOM) in acquisition transactions.
Mr. Shoff has represented issuers and underwriters in IPOs and other public offerings of companies such as Altiris, Inc. (acquired by SYMC), Halozyme Therapeutics, Inc. (HALO), Myriad Genetics, Inc. (MYGN), NPS Pharmaceuticals, Inc. (NPSP), Omniture, Inc. (OMTR) and Overstock.com, Inc. (OSTK).
- Harvard Law School
- Weber State University